Swiss Life Asset Management’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
Other funds holding EXEL
VPM
VCM
Swiss Life Asset Management's EXEL Position: Q2 2026 in Review
Swiss Life Asset Management reduced its Exelixis (EXEL) stake by 7.2% in Q2 2026, selling an estimated $77.5K and leaving 20,621 shares worth $1.12M. The position accounts for ﹤0.01% of the portfolio, ranked #673.
Swiss Life Asset Management first reported a position in EXEL in Q2 2025 and has held it in 5 quarters since. 598 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.
- Swiss Life Asset Management held 20,621 shares of Exelixis worth $1.12M as of Q2 2026.
- Swiss Life Asset Management sold 1,591 Exelixis shares in Q2 2026, an estimated $77.5K.
- Exelixis made up ﹤0.01% of Swiss Life Asset Management's portfolio in Q2 2026, its #673 holding.
- Swiss Life Asset Management first reported a position in Exelixis in Q2 2025 and has held it in 5 quarters since.
- 598 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.
Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.